CV Sciences (CVSI) Equity Ratio (2010 - 2026)

CV Sciences has disclosed Equity Ratio across 17 years of filings, most recently posting 0.22 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.22, down 8.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.22 (down 8.59% YoY), and the FY2025 annual result was 0.21, down 6.88% from the prior year.
• Equity Ratio came in at 0.22 for Q1 2026 at CV Sciences, up from 0.21 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.44 in Q1 2023 to a low of 0.06 in Q4 2022.
• The 5-year median for Equity Ratio is 0.23 (2025), against an average of 0.24.
• Across the five-year window, Equity Ratio sank 131.11% in 2022 and soared 617.22% in 2023, its largest moves.
• CV Sciences' Equity Ratio stood at 0.06 in 2022, then surged by 617.22% to 0.32 in 2023, then declined by 28.24% to 0.23 in 2024, then slipped by 6.88% to 0.21 in 2025, then advanced by 5.69% to 0.22 in 2026.
• The last three Equity Ratio figures came in at 0.22 (Q1 2026), 0.21 (Q4 2025), and 0.22 (Q3 2025), per Business Quant data.